Partially endothelium-dependent vasodilator effect of adenosine in rat aorta

Hypertension. 1988 Jun;11(6 Pt 1):514-8. doi: 10.1161/01.hyp.11.6.514.

Abstract

The vasodilator effect of adenosine on the contraction induced by phenylephrine, an alpha 1-adrenergic receptor agonist, was investigated in the isolated rat aorta. We found that the effect of adenosine was greater in intact aortas than in endothelium-denuded preparations. Denuding caused a parallel shift of the dose-response curve of adenosine to the right by a factor of five in comparison with intact aorta. This finding indicates that the relaxing effect of adenosine is partially endothelium-dependent in rat aorta. The mechanism of action of adenosine on vascular smooth muscle was also investigated in receptor-mediated and voltage-dependent calcium influx experiments performed with the addition of phenylephrine and high potassium concentrations, respectively. Although adenosine significantly inhibited only the tonic phase of the contraction induced by phenylephrine (10(-5) M), it did so to both the fast and slow phases of the contraction produced by high potassium concentrations (75 mM) with no preferential difference. In comparison to verapamil, a calcium entry blocker, adenosine behaved in a manner similar to that of verapamil in counteracting the constriction induced by either phenylephrine or potassium. We conclude that the vasodilator effect of adenosine is partially endothelium-dependent and that the mechanism of this effect may involve the inhibition of calcium influx and the release of an endothelium-derived relaxing factor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / administration & dosage
  • Adenosine / pharmacology*
  • Animals
  • Aorta / cytology
  • Aorta / drug effects*
  • Biological Products / administration & dosage
  • Biological Products / pharmacology*
  • Calcium / antagonists & inhibitors
  • Dose-Response Relationship, Drug
  • Female
  • Isometric Contraction
  • Male
  • Muscle Contraction / drug effects*
  • Muscle, Smooth, Vascular / drug effects*
  • Nitric Oxide
  • Phenylephrine / pharmacology
  • Potassium / pharmacology
  • Rats
  • Time Factors
  • Vasodilation / drug effects*
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / pharmacology*
  • Verapamil / pharmacology

Substances

  • Biological Products
  • Vasodilator Agents
  • Phenylephrine
  • Nitric Oxide
  • Verapamil
  • Adenosine
  • Potassium
  • Calcium